stockrow
Friday 6 November 2026
Export XAGE’s income statement to Excel — free account
Longevity Health Holdings, Inc.
XAGE Consumer Defensive Household & Personal Products
Longevity Health Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, up 3,702.8% from fiscal 2024.
- Revenue
- −21.4%
- EPS
- +51.3%
- Free cash flow
- +73.2%
Quarter to June 2026, against a year earlier
0.11
0.00
0.00%
Follow XAGE
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | 0 | 2 | 2 | +3,702.8% | — | — | — | — | |
| Gross margin, % | — | — | — | — | — | — | — | — | 87.48 | 57.24 | 58.98 | (30.2) pt | ||||||
| EBT | — | — | — | — | — | 0 | (9) | (16) | (11) | (7) | (7) | +113.7% | ||||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (21,367.20) | (359.11) | (402.67) | (359.1) pt | ||||||
| Net income | — | 0 | — | — | — | 0 | (9) | (16) | (11) | (7) | (7) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.07 | 1.34 | 0.68 | n/m | |||||
| Earnings | — | — | — | — | — | (2.47) | (154.72) | (43.84) | (15.17) | (4.83) | (3.49) | +18.3% | ||||||
| Cash flow | — | — | — | — | — | (3.38) | (58.61) | (22.75) | (5.47) | (2.33) | (0.99) | (8.9%) | ||||||
| Capex | — | — | — | — | — | 0.00 | (0.12) | (0.08) | 0.00 | (0.01) | 0.00 | n/m | ||||||
| Free cash flow | — | — | — | — | — | (3.38) | (58.73) | (22.83) | (5.47) | (2.34) | (0.99) | (8.8%) | ||||||
| Book value | — | — | — | — | — | (35.70) | (108.97) | 67.44 | (6.62) | (4.10) | (3.51) | (41.8%) | ||||||
| Shares, m | — | — | — | — | — | 0 | 0 | 0 | 1 | 1 | 2 | +80.9% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.0 | |||||
| P/S | — | — | — | — | — | — | — | — | 1.58 | 0.22 | 0.16 | 0.9 | ||||||
| P/B | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/Sales | — | — | — | — | — | — | — | — | 1.93 | 0.64 | 1.03 | 1.3 | ||||||
| EV/FCF | — | — | — | — | — | — | — | — | (1.86) | (0.36) | (0.70) | (1.1) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | 0 | (3) | (8) | (4) | (3) | (2) | +64.8% | |||||
| Capex | — | — | — | — | — | — | 0 | 0 | — | 0 | 0 | +25.4% | ||||||
| Free cash flow | — | — | — | — | — | 0 | (3) | (8) | (4) | (3) | (2) | +65.0% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 1 | (7) | 24 | (5) | (6) | (9) | n/m | |||||
| Net debt | — | — | — | — | — | (1) | 0 | (3) | 0 | (1) | 0 | (2.3%) | ||||||
| Shareholders’ equity | — | — | — | — | — | (5) | (6) | 25 | (5) | (6) | (9) | +5.4% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | (0.42) | (12.23) | (49.08) | (31.70) | (359.56) | (286.02) | (359.1) pt | |||||
| ROIC | — | — | — | — | — | 0.00 | 0.00 | (17.01) | 0.00 | 0.00 | 0.00 | 0.0 pt | ||||||
| ROE | — | — | — | — | — | 0.00 | 45.16 | 247.23 | (103.50) | 130.54 | 109.80 | +130.5 pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | 0 | — | 9 | 15 | 10 | — | n/m | |||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | — | 0.00 | 0.00 | 0.19 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026
Longevity Health Holdings, Inc. vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| SLSN Solesence, Inc. | $61.2M | — (loss-making) | — | −24.69% (below 0%: shrinking) | n/m | +86.52% (above 0%: growing) | 30.97% | 0.79% | Compare |
| GROV Grove Collaborative Holdings, Inc. | $44.8M | — (loss-making) | — (loss-making) | −16.94% (below 0%: shrinking) | n/m | +101.08% (above 0%: growing) | 53.56% | (2.14%) | Compare |
| UG United-Guardian, Inc. | $31.2M | 12.6× | 18.7× | +9.52% (above 0%: growing) | +14.29% (above 0%: growing) | +428.43% (above 0%: growing) | 49.73% | 24.26% | Compare |
| DSY Big Tree Cloud Holdings Limited | $15.4M | 17.8× | — | — | 0.00% | −267.22% (below 0%: shrinking) | — | — | Compare |
| ATTT Atlas Trinity Tech Limited | $11.9M | — | — | — | — | −192.00% (below 0%: shrinking) | — | — | Compare |
| TANH Tantech Holdings Ltd. | $9.0M | — (loss-making) | 0.7× | −4.32% (below 0%: shrinking) | +102.50% (above 0%: growing) | −214.50% (below 0%: shrinking) | 20.52% | 0.00% | Compare |
| BRSHF Bruush Oral Care Inc. | $8.7M | — (loss-making) | — | +7.78% (above 0%: growing) | n/m | −241.22% (below 0%: shrinking) | 75.64% | (488.63%) | Compare |
| BYAH Park Ha Biological Technology Co., Ltd. | $4.9M | — | — | — | — | −138.75% (below 0%: shrinking) | — | — | Compare |
| XAGE Longevity Health Holdings, Inc. | $1.6M | — (loss-making) | — | −21.37% (below 0%: shrinking) | n/m | +73.22% (above 0%: growing) | 59.47% | (182.88%) | |
| Median of peers | $13.7M | — | — | −4.32% | +14.29% | −165.37% | 49.73% | 0.00% |